Bentham Science Logo

Track Your Manuscript:


Current Drug Safety

Volume 16, 3 Issues, 2021
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access

Contents

Current Drug Safety, Volume 3 - Number 2






Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Data

, 3(2): 132 - 142

Joachim Wernicke, Beth Pangallo, Fujun Wang, Isabelle Murray, Judith W. Henck, Mary Pat Knadler, Deborah N. D'Souza and Jack P. Uetrecht


DOI: 10.2174/157488608784529189


Hepatic Effects of Duloxetine-II: Spontaneous Reports and Epidemiology of Hepatic Events

, 3(2): 143 - 153

Joachim Wernicke, Nayan Acharya, Indiana Strombom, James L. Gahimer, Deborah N. D'Souza, Natalie DiPietro and Jack P. Uetrecht


DOI: 10.2174/157488608784529198





Editor-in-Chief

Seetal Dodd
School of Medicine
University of Melbourne
Geelong, Melbourne
(Australia)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog